(1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide

C41H60N6O12 — CID 24949744

IUPAC(1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2OC(C)CC(N(C)C)C2O)[C@@](C)(OC)C[C@@H](C)C(=O)C(C)C2C(/C(N)=N\OCc3nc(-c4cccnc4)no3)C(=O)O[C@@]21C
InChIInChI=1S/C41H60N6O12/c1-12-27-41(8)30(29(38(52)58-41)35(42)45-54-19-28-44-36(46-59-28)25-14-13-15-43-18-25)22(4)31(48)20(2)17-40(7,53-11)34(23(5)32(49)24(6)37(51)56-27)57-39-33(50)26(47(9)10)16-21(3)55-39/h13-15,18,20-24,26-27,29-30,33-34,39,50H,12,16-17,19H2,1-11H3,(H2,42,45)/t20-,21?,22?,23+,24-,26?,27-,29?,30?,33?,34-,39?,40+,41-/m1/s1
InChIKeyYOHYIDYBFQDWBZ-LBWQGCIESA-N
MW828.96 g/mol
LogP3.09
Rot. Bonds10

About (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide

(1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide (PubChem CID 24949744) has the molecular formula C41H60N6O12 and a molecular weight of 828.96 g/mol. Its IUPAC name is (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide.

Molecular Properties

Compound Name(1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide
PubChem CID24949744
Molecular FormulaC41H60N6O12
Molecular Weight828.96 g/mol
Exact Mass828.43
IUPAC Name(1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2OC(C)CC(N(C)C)C2O)[C@@](C)(OC)C[C@@H](C)C(=O)C(C)C2C(/C(N)=N\OCc3nc(-c4cccnc4)no3)C(=O)O[C@@]21C
InChIInChI=1S/C41H60N6O12/c1-12-27-41(8)30(29(38(52)58-41)35(42)45-54-19-28-44-36(46-59-28)25-14-13-15-43-18-25)22(4)31(48)20(2)17-40(7,53-11)34(23(5)32(49)24(6)37(51)56-27)57-39-33(50)26(47(9)10)16-21(3)55-39/h13-15,18,20-24,26-27,29-30,33-34,39,50H,12,16-17,19H2,1-11H3,(H2,42,45)/t20-,21?,22?,23+,24-,26?,27-,29?,30?,33?,34-,39?,40+,41-/m1/s1
InChIKeyYOHYIDYBFQDWBZ-LBWQGCIESA-N
XLogP3.09
TPSA237.32 Ų
H-Bond Donors2
H-Bond Acceptors17
Rotatable Bonds10
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500828.96
LogP ≤ 53.09
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide?
The IUPAC name of (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide (CID 24949744) is (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide.
What is the SMILES notation for (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide?
The canonical SMILES for (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2OC(C)CC(N(C)C)C2O)[C@@](C)(OC)C[C@@H](C)C(=O)C(C)C2C(/C(N)=N\OCc3nc(-c4cccnc4)no3)C(=O)O[C@@]21C.
What is the InChIKey of (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide?
The InChIKey is YOHYIDYBFQDWBZ-LBWQGCIESA-N. The full InChI is InChI=1S/C41H60N6O12/c1-12-27-41(8)30(29(38(52)58-41)35(42)45-54-19-28-44-36(46-59-28)25-14-13-15-43-18-25)22(4)31(48)20(2)17-40(7,53-11)34(23(5)32(49)24(6)37(51)56-27)57-39-33(50)26(47(9)10)16-21(3)55-39/h13-15,18,20-24,26-27,29-30,33-34,39,50H,12,16-17,19H2,1-11H3,(H2,42,45)/t20-,21?,22?,23+,24-,26?,27-,29?,30?,33?,34-,39?,40+,41-/m1/s1.
What are the key properties of (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide?
(1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide has a molecular weight of 828.96 g/mol, XLogP of 3.09, 10 rotatable bonds, 2 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,5R,7R,8R,9S,11R,13R)-8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,6,12,16-tetraoxo-N'-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)methoxy]-3,17-dioxabicyclo[12.3.0]heptadecane-15-carboximidamide is sourced from PubChem (CID 24949744), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).